Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Edwards Lifesciences Corporation EW NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
74/100
6/7 Pass
SharesGrow Intrinsic Value
$108.39
+38.6%
Analyst Price Target
$96.38
+23.2%
Metric TTM (2025-03 – 2025-12)
Operating Cash Flow $1.6B
Capital Expenditure $-260.2M
Free Cash Flow $1.34B

People Also View

ABT
ABT
Abbott Laboratories
$101.07
+0.38%
 SYK
SYK
Stryker Corporation
$345.88
-0.39%
 MDT
MDT
Medtronic plc
$88.12
+0.14%
 BSX
BSX
Boston Scientific Corporation
$63.82
+1.01%
 BDX
BDX
Becton, Dickinson and Company
$155.73
+0.19%
 ARGX
ARGX
argenx SE
$828.35
+2.36%
 CAH
CAH
Cardinal Health, Inc.
$214.95
+0.36%
 HLN
HLN
Haleon plc
$9.70
-1.32%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message